# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-20-001710
Filing Date
2020-03-13
Accepted
2020-03-13 15:36:11
Documents
75
Period of Report
2019-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | f10k_031320p.htm | 10-K | 1094264
2 | EXHIBIT 4.1 | exh_41.htm | EX-4.1 | 12277
3 | EXHIBIT 10.18 | exh_1018.htm | EX-10.18 | 45264
4 | EXHIBIT 10.83 | exh_1083.htm | EX-10.83 | 747348
5 | EXHIBIT 21 | exh_21.htm | EX-21 | 2106
6 | EXHIBIT 23 | exh_23.htm | EX-23 | 5762
7 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 7919
8 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 4277
15 | GRAPHIC | graph1.jpg | GRAPHIC | 16113
| Complete submission text file | 0001171843-20-001710.txt |  | 7121596

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE FILE | bcrx-20191231.xml | EX-101.INS | 1190023
10 | XBRL SCHEMA FILE | bcrx-20191231.xsd | EX-101.SCH | 72519
11 | XBRL CALCULATION FILE | bcrx-20191231_cal.xml | EX-101.CAL | 55080
12 | XBRL DEFINITION FILE | bcrx-20191231_def.xml | EX-101.DEF | 498026
13 | XBRL LABEL FILE | bcrx-20191231_lab.xml | EX-101.LAB | 468090
14 | XBRL PRESENTATION FILE | bcrx-20191231_pre.xml | EX-101.PRE | 526711

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 20712407
SIC: 2836 Biological Products, (No Diagnostic Substances)